Evidence map›Paper›PMID 22085394›Full record

ArticleGenetic testing and molecular biomarkers2012

Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.

McKane E Sharff, Tiffani A DeMarco, Darren Mays, Beth N Peshkin, Heiddis B Valdimarsdottir, Judy E Garber, Katherine A Schneider, Andrea F Patenaude, Kenneth P Tercyak

Open access · greenAbstract read
In one paragraph

Article in Genetic testing and molecular biomarkers, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Development of a Tool to Guide Parents Carrying a BRCA1/2 Mutation Share Genetic Results with Underage Children.Journal of cancer education : the official journal of the American Association for Cancer Education · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2014
    Article
  15. Effects of undergoing multiplex genetic susceptibility testing on parent attitudes towards testing their children.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2014
    Article
  16. Article
  17. Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

McKane E SharffLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA.
Tiffani A DeMarco
Darren Mays
Beth N Peshkin
Heiddis B Valdimarsdottir
Judy E Garber
Katherine A Schneider
Andrea F Patenaude
Kenneth P Tercyak
Dana-Farber Cancer Institute · USGeorgetown University Medical Center · USGeorgetown University · USIcahn School of Medicine at Mount Sinai · US

Funding

Parent Communication of BRCA1/2 Test Results to ChildrenR01HG002686 · NHGRI · GEORGETOWN UNIVERSITY · PI TERCYAK, KENNETH · 2003 to 2009
$3.1M
NHGRI NIH HHS R01 HG002686
6 · The paper itself

Abstract

aimAmong mothers undergoing BRCA1/2 testing and their spouses/partners, this study sought to examine decision support needs and motivations for family communication of genetic risk information to asymptomatic children.

methodsThis study gathered data from 213 tested mothers and 104 of their untested parenting partners 1 month after maternal receipt of genetic test results and upon making a decision about communicating genetic information to their child (ages 8-21 years). Data include parents' perceived needs for family communication decision support, decision motivations, and parent-child communication.

resultsParents reported high decision support needs (e.g., educational materials, professional counseling, peer assistance). Motivations for disclosure to children among mothers and partners focused on promoting the parent-child bond and maintaining family health (55.3% and 75%, respectively) and promoting positive child affect (44.7% and 25.5%, respectively). Motivations for nondisclosure to children among mothers and partners focused on the lack of appropriateness (69.6% and 51.3%, respectively) and relative importance of genetic test results (30.4% and 48.7%, respectively). Significant discrepancies in parental motivation for family communication were observed. Decision support needs were highest among disclosing mothers with affect-related motivations [t (129)=2.47; p=0.01]. Parent-child communication was poorest among nondisclosing mothers concerned about the appropriateness of genetic information for their child [t (77)=-3.29; p=.002].

conclusionsParents receiving information about hereditary cancer predisposition have unmet needs when making decisions about disclosing genetic risk information to their asymptomatic children. These data can guide the development of cancer risk communication decision support interventions for parents undergoing such testing.

Indexed as

Genetic Predisposition to DiseaseParent-Child RelationsTruth DisclosureAdolescentAdultBreast NeoplasmsChildDecision MakingFemaleGenes, BRCA1Genes, BRCA2Genetic CounselingGenetic TestingHumansMaleMiddle Aged

Identifiers

PMID22085394
PMCPMC3354582
OpenAlexW2093148166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.